Endocrine News — Blog Content

FDA Approves First Ready-to-Use Stable Liquid Glucagon for Severe Hypoglycemia

The U.S. Food and Drug Administration (FDA) recently approved a ready-to-use, room-temperature stable liquid glucagon for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages 2 years and above. Xeris Pharmaceuticals is marketing this new glucagon injection as GVOKE. GVOKE is the first glucagon product approved that can be administered via...

ArticlesHenry AnhaltSeptember 1, 2019Endocrine News, FDA, Liquid Glucagon, Hypoglycemia

Society Brings Researchers to Capitol Hill to Advocate for NIH Funding

Springtime in Washington, D.C., always includes cherry blossoms; bus loads of tourists visiting the national monuments, memorials, and museums; and groups who come to Capitol Hill to advocate on issues Congress is considering. The Endocrine Society is no exception.

ArticlesHenry AnhaltJune 1, 2018NIH, Advocacy, Hill Day, Endocrine Society, Endocrine News, Artificial Pancreas, short stature/growth

© 2020 Henry Anhalt, DO

Site Map

Social Media

Join The Mailing List